131
Views
36
CrossRef citations to date
0
Altmetric
Original Research

Nutritional Support in Alcoholic Cirrhotic Patients Improves Host Defenses

, MD, MSc, , MD, MSc, , , , MSc, , PhD, , MSc, , MSc & , MD show all
Pages 434-441 | Received 01 Feb 1999, Accepted 01 Jul 1999, Published online: 07 Jun 2013

REFERENCES

  • Mendenhall CL, Anderson SH, Weesner RE, Goldberg SJ, Crolic KA: Protein-caloric malnutrition associated with alcoholic hepatitis. Am J Med 76: 211–222, 1984.
  • Bollet AJ, Owen S: Evaluation of nutritional status of selected hospitalized patients. Am J Clin Nutr 26: 931–938, 1973.
  • Bunout D, Aicardi V, Hirsch S, Petermann M, Kelly M, Silva G, Garay P, Ugarte G, Iturriaga H: Nutritional support in hospitalized patients with alcoholic liver disease. Eur J Clin Nutr 43: 615–621, 1989.
  • Hirsch S, Bunout D, De la Maza MP, Iturriaga H, Petermann M, Icaza G, Gattas V, Ugarte G: Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. JPEN 17: 119–124, 1993.
  • Cabré E, Gassull MA: Nutritional aspects of chronic liver disease. Clin Nutr 12: S52–S63, 1993.
  • McCullough AJ, Mullen KD, Kalhan SC: Body cell mass and leucine metabolism in cirrhosis. Gastroenterology 102: 1325–1333, 1992.
  • McCullough AJ, Mullen KD, Tavill AS, Kalhan SC: In vivo differences between the turnover rates of leucine and leucine’s ketoacid in stable cirrhosis. Gastroenterology 103: 571–578, 1992.
  • Hirsch S, De la Maza MP, Petermann M, Iturriaga H, Ugarte G, Bunout D: Protein turnover in abstinent and non abstinent patients with alcoholic liver disease. J Am Coll Nutr 14: 99–103, 1995.
  • Marchesini G, Zoli M, Angiolini A, Dondi C, Bianchi F, Pisi E: Muscle protein breakdown in liver cirrhosis and the roll of carbohydrate metabolism. Hepatology 1: 294–299, 1981.
  • Mullen KD, Denne SC, McCullough AJ, Savin SM, Bruno D, Tavill AS, Kalhan SC: Leucine metabolism in stable cirrhosis. Hepatology 6: 622–630, 1986.
  • Dichi I, Dichi JB, Papini-Berto SJ, Angeleli AYO, Bicudo MH, Rezende TA, Burini RC: Protein-energy status and 15N-glycine kinetic study of Child A cirrhotic patients fed low- to high-protein energy diets. Nutrition 12: 519–523, 1996.
  • Merli M, Riggio O, Romiti A, Franco A, Mango L, Pinto G, Savioli M, Capocaccia L: Basal energy production rate and substrate use in stable cirrhotic patients. Hepatology 12: 106–112, 1990.
  • Owen OE, Reichle FA, Mozzoli MA, Moctezuma J, Paul P, Skutches CL, Boden G: Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 72: 1821–1832, 1983.
  • Jhangiani SS, Agarwal N, Holmes R, Cayten CG, Pitchumoni CS: Energy expenditure in chronic alcoholics with and without liver disease. Am J Clin Nutr 44: 323–329, 1986.
  • Shanbhogue RLK, Bistrian BR, Jenkins RL, Jones C, Benotti P, Blackburn GL: Resting energy expenditure in patients with end stage liver disease and in normal population. JPEN 11: 305–308, 1987.
  • Riggio O, Merli M, Romiti A, Pinto G, Fanella R, Attilia AF, Capocaccia L: Early postprandial energy expenditure and macronutrient use after a mixed meal in cirrhotic patients. JPEN 16: 445–450, 1992.
  • Müller M, Lautz H, Plogmann B, Bürger M, Körber J, Schmidt F: Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 15: 782–794, 1992.
  • Dolz C, Ranrich JM, Ibañez J, Obrados P, Marse P, Gaya J: Ascites increases the resting energy expenditure in liver cirrhosis. Gastroenterology 100: 738–744, 1991.
  • Santos JI: Nutrition, infection and immunocompetence. Infect Dis Clin N Am 8: 243–267, 1994.
  • Deitch EA: Bacterial translocation: the influence of dietary variables. Gut 1: S23–S27, 1994.
  • Edmiston CE, Condon RE: Bacterial translocation. Surg Gynecol and Obst 173: 73–83, 1991.
  • Welsh FK, Farmery SM, MacLennan K, Sheridan MB, Barclay GR, Guillou PJ, Reynolds JV: Gut barrier function in malnourished patients. Gut 42: 396–401, 1998.
  • Geefhuysen J, Rosen EU, Katz J, Ipp T, Metz J: Impaired cellular immunity in Kwashiorkor with improvement after therapy. Br Med J 4: 527–529, 1971.
  • Reinhardt GF, Myscofsky JW, Wilkens DB: Incidence and mortality of hypoalbuminemic patients in hospitalized veterans. JPEN 4: 357–359, 1981.
  • Braga M, Baccari P, Scaccabarozzi S, Fiacco E, Radaelli G, Gallus G, DiPalo S, DiCarlo V, Cristallo M: Prognostic role of preoperative nutritional and immunological assessment in the surgical patient. JPEN 12: 138–142, 1988.
  • Mendenhall CL, Tosch T, Weesner RE, García-Pont P, Goldberg SJ, Kiernan T, Seeff LB, Soviell M, Tamburro C, Zetterman R, Chedid A, Chen T, Rabin L: VA cooperative study on alcoholic hepatitis II. Prognostic significance of protein-calorie malnutrition. Am J Clin Nutr 43: 213–218, 1986.
  • Nasrallah JM, Galambos JT: Amino acid therapy of alcoholic hepatitis. Lancet 2: 1276–1277, 1980.
  • Nompleggi DJ, Bonkovsky HL: Nutritional supplementation in chronic liver disease: An analytical review. Hepatology 19: 518–533, 1994.
  • Pugh RNH, Murray-lyon MI, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646–650, 1973.
  • Hirsch S, Obaldía N, Petermann M, Rojo P, Barrientos C, Iturriaga H, Bunout D: Subjective global assessment of nutritional status: further validation. Nutrition 7: 23–25, 1991.
  • Hirsch S, Muñoz C, De la Maza MP, Petermann M, López M, Schlesinger L, Bunout D: Increased cytokines production is associated with acute inflammation in cirrhotic alcoholic patients. (1950386) International Hepatology Communications 6: 166–174, 1997.
  • Scott BB, Barclay GR: Endotoxin-polymyxin complexes in an improved enzyme-linked immunosorbent assay for IgG antibodies in blood donor sera gram-negative endotoxin core glicolipid. Vox Sang 52: 272–280, 1987.
  • Pereira SP, Khin-Maung U, Bolin TD, Duncombe VM, Nyunt-Nyunt-Wai, Myo-Khin, Linklater JM: A pattern of breath hydrogen excretion suggesting small bowel bacterial overgrowth in Burmese village children. Ped Gastroenterol Nutr 13: 32–38, 1991.
  • De la Maza MP, Petermann M, Bunout D, Hirsch S: Effects of long-term vitamin-E supplementation in alcoholic cirrhotic. J Am Coll Nutr 14: 192–196, 1995.
  • Matthews DE, Heymsfield SB: A.S.P.E.N. 1990 Research workshop on energy metabolism. JPEN 15: 3–14, 1991.
  • Madden AM, Morgan MY: The potential role of dual-energy X-ray absortiometry in the assessment of body composition in cirrhotic patients. Nutrition 13: 40–45, 1997.
  • Davidson HI, Richardson R, Sutherland D, Garden OJ: Macronutrient preference, dietary intake, and substrate oxidation among stable cirrhotic patents. Hepatology 29: 1380–1386, 1999.
  • Santos MS, Leka LS, RibayaMercado JD, Russell RM, Meydani M, Hennekens CH, Gaziano JM, Meydani SM: Short and long term β-carotene supplementation do not influence cell mediated immunity in healthy elderly persons. Am J Clin Nutr 66: 917–924, 1997.
  • Mutchnick MG, Lee HH: Impaired lymphocyte proliferative response to mitogen in alcoholic patients. Absence of a relation to liver disease activity. Alcoholism 12: 155–158, 1988.
  • Smith FE, Palmer DL: Alcoholism, infection and altered host defenses. J of Chronic Dis 29: 35–49, 1976.
  • Chandra RK: Nutrition, immunity and infection: present knowledge and future directions. Lancet 1: 688–691, 1983.
  • Chandra RK: Effects of nutrition on the immune system. Nutrition 10: 207–210, 1994.
  • Detsky AS, Baker JP, McLaughlin JR, Jeejeebhoy KN: What is subjective global assessment of nutrition status. JPEN 11: 8–12, 1987.
  • Adachi Y, Moore LE, Bradford BU, Gao W, Trurman RG: Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1088: 218–224, 1995.
  • Llovet JM, Bartolí R, Planas R, Cabré E, Jimenez M, Urban A, Ojanguren I, Arnal J, Gassull MA: Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut 35: 1648–1652, 1994.
  • Bjarnason I, MacPherson A, Hollander A: Intestinal permeability: an overview. Gastroenterology 108: 1566–1581, 1995.
  • Lumsden AB, Henderson JM, Kutner MH: Endotoxin levels measured by chromogenic assay in portal hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8: 232–236, 1988.
  • Bode C, Schafer C, Fukui H, Bode JC: Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease—a double-blind, placebo-controlled trial. Alcohol Clin Exp Res 21: 1367–1373, 1997.
  • Budillon G, Parrilli G, Pacella M, Cuomo R, Menzies IS: Investigation of intestine and liver function in cirrhosis using combined sugar oral loads. J Hepatol 1: 513–524, 1985.
  • Reynolds JV, Kanwar S, Welsh FKS, Windsor ACJ, Murchan P, Barclay GR, Guillou PJ: Does the route of feeding modify gut barrier function and clinical outcome in patients after major upper gastrointestinal surgery? JPEN 21: 196–201, 1997.
  • Van Leeuwen PAM, Boermeester MA, Houdijk APJ, Ferwerda CH, Cuesta MA, Meyer S, Wesdorp RIC: Clinical significance of translocation. Gut 35Supp: S28–S34, 1994.
  • Bjarnason I: Intestinal permeability. Gut 35Supp: S18–S22, 1994.
  • Hirsch S, Cháves G, Gotteland M, De la Maza P, Petermann M, Barrera P, Bunout D: Permeabilidad intestinal en alcohólicos sin daño hepático. Rev Med Chile 125: 653–658, 1997.
  • Espinoza J, Brunser O, Araya M: Colonización Bacteriana anormal del intestino delgado alto en escolares de nivel socioeconómico alto y bajo. Rev Chil Pediatr 64: 364–370, 1993.
  • Bode JC, Heidelbach R, Bode C, Mannheim W, Dürr HK, Martini GA: Bacterial miclofora in the jejunum of chronic alcoholics. INSERM 95: 451–456, 1980.
  • Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI: Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13: 267–276, 1991.
  • Napoli J, Bishop GA, McCaughan GW: Increased intrahepatic messenger RNA expression of interleukins 2, 6 and 8 in human cirrhosis. Gastroenterology 107: 789–798, 1994.
  • Byl B, Deviere J: The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 20: 1343–1350, 1994.
  • Propst T, Propst A, Herold M, Schauer G, Judmaier G, Braunsteiner H, Stoffler G, Vogel W: Eur J Clin Invest 23: 832–836, 1993.
  • Spitz JC, Ghandi S, Taveras M, Aoys E, Alverdy JC: Characteristics of the intestinal epithelial barrier during dietary manipulation and glucocorticoid stress. Crit Care Med 24: 635–641, 1996.
  • Castillo-Duran C, Heresi G, Fisberg M, Uauy R: Controlled trial of zinc supplementation during recovery from malnutrition: effects on growth and immune function. Am J Clin Nutr 45: 602–608, 1987.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.